These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 209578)

  • 1. [Study of the biochemical and radiochemical effects of the agent MTDQ (author's transl].
    Pollák ZB; Rodé I; Bär V
    Strahlentherapie; 1978 Jul; 154(7):499-502. PubMed ID: 209578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation on radiosensitizing and tumor inhibiting actions of the antioxidant MTDQ (6,6'-methylen-bis/2,2,4-trimethyl-1-1,2-dihydroquinolin) (author's transl)].
    Bär V; Foris G; Erdélyi V; Pollák Z; Eckhardt S
    Arch Geschwulstforsch; 1975; 45(5):489-95. PubMed ID: 1212067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials with MTDQ /6,6'-methylene-bis (2,2,4-trimethyl-1,2-dihydroquinoline)/ an antioxidant with radiation sensitizing effect.
    Erdélyi V; Bär V; Pollák Z; Fodor J; Kralovánszky J; Tóth I; Hindy I; Eckhardt S
    Strahlentherapie; 1980 Mar; 156(3):198-200. PubMed ID: 6987780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of radiosensitization in Lewis lung carcinoma and a murine plasmacytoma by MTDQ and MTDQ-DA.
    Schlappack OK; Peacock JH; Haslinger RK; Schmidt WF; Eady JJ
    Strahlenther Onkol; 1988 Nov; 164(11):684-8. PubMed ID: 3201385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmacological investigation of 6,6'methylene-bis/2,2,4-trimethyl-1,2-dihydroquinoline (MTDQ) a radical binding antioxidant of secondary amine type.
    Bär V; Erdélyi V; Foris G; Pollák Z; Eckhardt S
    Neoplasma; 1977; 24(3):253-8. PubMed ID: 895935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo.
    Hofstetter B; Vuong V; Broggini-Tenzer A; Bodis S; Ciernik IF; Fabbro D; Wartmann M; Folkers G; Pruschy M
    Clin Cancer Res; 2005 Feb; 11(4):1588-96. PubMed ID: 15746064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by an antioxidant of the carcinogenic effect of nitrosomorpholine formed in vivo.
    Börzsönyi M; Torok G; Pinter A; Surján A; Csik M; Bar V
    IARC Sci Publ; 1982; (41):659-64. PubMed ID: 7141573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin.
    Kranjc S; Cemazar M; Grosel A; Scancar J; Sersa G
    Anticancer Res; 2003; 23(1A):275-81. PubMed ID: 12680224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol.
    Kumar KS; Raghavan M; Hieber K; Ege C; Mog S; Parra N; Hildabrand A; Singh V; Srinivasan V; Toles R; Karikari P; Petrovics G; Seed T; Srivastava S; Papas A
    Life Sci; 2006 Mar; 78(18):2099-104. PubMed ID: 16413038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization.
    Devi PU
    Indian J Exp Biol; 1996 Oct; 34(10):927-32. PubMed ID: 9055640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature.
    Murphy JD; Spalding AC; Somnay YR; Markwart S; Ray ME; Hamstra DA
    Clin Cancer Res; 2009 Jan; 15(2):589-96. PubMed ID: 19147764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
    Rockwell S; Kelley M
    Radiat Oncol Investig; 1998; 6(5):199-208. PubMed ID: 9822166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy.
    Moding EJ; Castle KD; Perez BA; Oh P; Min HD; Norris H; Ma Y; Cardona DM; Lee CL; Kirsch DG
    Sci Transl Med; 2015 Mar; 7(278):278ra34. PubMed ID: 25761890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The radiosensitizing action of some organic peroxides].
    Tiunov LA; Kachurina NA; Smirnova OI
    Radiobiologiia; 1966; 6(3):343-8. PubMed ID: 5983917
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
    Skov KA; Adomat H; Doedee M; Farrell N
    Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
    Papadopoulou MV; Bloomer WD; Hollingshead MG
    Anticancer Res; 2005; 25(3B):1865-9. PubMed ID: 16158918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
    Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
    Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined effect of interferon inducers, radiosensitizing and antineoplastic agents on solid tumors].
    Leonidze DL
    Radiobiologiia; 1987; 27(5):696-9. PubMed ID: 3671688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiinflammatory effect of the antioxidant MTDQ-DS.
    Molnár I; Budavári I; Nánási A; Gyires K; Ikrényi K
    Int J Tissue React; 1985; 7(6):463-8. PubMed ID: 4086218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.